BEE International

What BEE International does

BEE International is a privately held US-based supplier and manufacturer (founded 1994, headquartered in South Easton, Massachusetts) whose product portfolio, as reflected in the source data, centers on proprietary analytical instruments and in vitro tools for pharmaceutical drug development and formulation science. The instrument family includes the Rainbow R6 in situ UV-Vis dissolution and permeation monitor, the DissoSpec QC dissolution monitoring system, the SCISSOR N3 in vitro injection site simulator, the SiriusT3 automatic titration system for pKa and solubility, the PrepEngine high-throughput sample preparation system, and the PAMPA permeability assay system. Together these address oral drug formulation, injectable formulation development, and physicochemical characterization workflows for drug developers.

The company runs a hybrid go-to-market combining direct enterprise sales — featuring 'Request a Demo' and 'Contact Us' pathways — with a global distributor network surfaced through a 'Locate a Distributor' feature. Revenue is generated primarily through one-time hardware sales of analytical instruments, complemented by fee-for-service analytical testing and multi-year service contracts; pricing is quote-based and not publicly disclosed. Primary customers are large and mid-sized pharmaceutical companies, drug developers and formulation scientists, and contract research organizations (CROs). Marketing is content-led, anchored on a scientific resource library, peer-reviewed publications (notably a 2025 Journal of Controlled Release article co-authored with AstraZeneca), industry events, and the company's own website.

Data note: The firmographics header describes BEE International as a high-pressure homogenizer manufacturer, while the detailed product, technology, and go-to-market blocks describe Pion Inc.'s pharmaceutical analytical instruments business. The description above reflects the more substantive product and commercial evidence present in the source material.

Name

BEE International

Legal name

Pion Inc.

Website

https://beei.com

Company type

Private

Founded year

1994

Operating status

Operating

Headcount range

11–50 employees

Short description

BEE International is a privately held US-based manufacturer and supplier of proprietary in vitro analytical instruments for pharmaceutical drug development, serving large and mid-sized pharma companies, formulation scientists, and CROs worldwide through direct sales and a global distributor network.

Ownership category

akta.pro rank

Headquarters

HQ city

South Easton

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Operations, Supply Chain, Marketing or Sales, Infrastructure

Revenue model

1. Analytical Instruments and Hardware Sales: Sale of proprietary pharmaceutical analysis instruments including dissolution monitors, titration systems, and assay equipment. One-time hardware purchases with potential service contracts.
2. Analytical Services: Fee-for-service analytical testing and characterization services for pharmaceutical companies conducting drug development studies.
3. Laboratory Technology Solutions: High-throughput sample preparation systems and related laboratory equipment for pharmaceutical R&D operations.

Pricing tiers

Go-to-market motion2 records

Distribution channels2 records

Marketing channels4 records

Core offering

BEE International, operating through its legal entity Pion Inc., designs, manufactures, and services proprietary pharmaceutical analytical instruments used in drug dissolution, formulation, and characterization workflows, including in situ UV-Vis dissolution monitors, QC dissolution systems, in vitro injection site simulators, automated pKa/solubility titrators, high-throughput sample preparation systems, and permeability assay platforms. The company also provides fee-based analytical services that complement its instrument portfolio for drug development customers.

Product overview

Pion provides a portfolio of analytical instruments and in vitro tools for pharmaceutical and drug development. The core product line includes dissolution monitoring systems (Rainbow R6, DissoSpec), physicochemical characterization tools (SiriusT3 for pKa and solubility, PAMPA for permeability screening), injectable formulation simulation (SCISSOR N3), and sample preparation automation (PrepEngine). These products support oral drug formulation and delivery development, injectable formulation development, and physicochemical characterization workflows, enabling drug developers to move from in vitro testing to in vivo applications.

Differentiator

Problem solved

Functional benefit

Brands

• Rainbow R6: Rainbow R6™ Dissolution and Permeation Monitor - enables in situ concentration monitoring for dissolution, absorption, solubility, and more
• DissoSpec
• SCISSOR N3
• SiriusT3
• PrepEngine
• PAMPA

Products and services

• Rainbow R6 In Situ UV-Vis Dissolution Monitoring System
• DissoSpec Dissolution Monitoring System for QC A dissolution monitoring instrument built for quality control environments, using in situ UV-Vis detection to provide regulator-acceptable dissolution data for pharmaceutical QC laboratories.
• SCISSOR N3 In Vitro Injection Site Simulator An in vitro instrument that simulates subcutaneous injection sites to study drug behavior after injection, used by pharmaceutical developers of injectable biologics and small molecules.
• SiriusT3 Automatic Titration System An automated potentiometric titration instrument that measures pKa and kinetic solubility of drug compounds in approximately 18 minutes, intended for pharmaceutical discovery and preformulation scientists.
• PrepEngine High-Throughput Sample Preparation System A high-throughput automated system for preparing pharmaceutical samples prior to analysis, used by drug development and analytical laboratories.
• PAMPA Permeability Assay System A Parallel Artificial Membrane Permeability Assay (PAMPA) instrument that measures passive permeability of drug compounds, used by pharmaceutical scientists in early drug discovery and preformulation.
• Analytical Services for Drug Development Fee-based analytical services that complement the company's instrument portfolio, providing drug development and pharmaceutical customers with outsourced dissolution, formulation, and analytical testing capacity.

Quantifiable outcome

• pKa measurements in 18 minutes using SiriusT3 Fast UV pKa Method

Named customers1 record

Segments3 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

One partnership is on record.

• AstraZenecacoreStrategic or Co-development PartnerCollaborative research partnership where AstraZeneca utilized Pion's SCISSOR N3 In Vitro Injection Site Simulator for injectable formulation research. Results were published in the Journal of Controlled Release 2025, demonstrating product validation and scientific collaboration in drug delivery technology.

Scale indicators1 record

Recent moves4 records

Expansion highlights4 records

Direct peers

• Distek: Manufacturer of dissolution, degradation, and pharmaceutical testing instruments. Closely comparable to Pion because both companies focus narrowly on pharmaceutical formulation and QC dissolution instruments for similar enterprise customers.
• Waters Corporation: Specialist in chromatography, mass spectrometry, and dissolution testing for pharmaceutical and life sciences customers. Directly comparable to Pion because Waters' dissolution systems and Empower software are widely deployed in the same pharma formulation and QC workflows Pion targets.
• Erweka: German manufacturer of pharmaceutical testing equipment including dissolution, hardness, and disintegration testers. Comparable to Pion as a focused pharmaceutical testing instrument vendor targeting the same R&D and QC formulation workflows.
• Hanson Research: Specialist in dissolution testing instruments and accessories for the pharmaceutical industry. Comparable to Pion because Hanson competes in the same dissolution USP apparatus market and serves the same formulation and QC customer base.
• Copley Scientific: UK-based specialist in pharmaceutical testing and inhaler/aerosol testing equipment. Comparable to Pion because both serve pharmaceutical R&D and QC labs with focused, regulated analytical instruments rather than broad industry tools.
• SOTAX: Specialist in dissolution testing, automated sample preparation, and pharmaceutical testing equipment. Most directly comparable to Pion as a focused dissolution/formulation instrument vendor serving the same pharmaceutical QC and R&D customers.

Broad incumbents

• METTLER TOLEDO: Global precision instruments manufacturer with a strong pharmaceutical lab portfolio including dissolution, titration, and pKa/solubility systems. Comparable to Pion because METTLER TOLEDO's pharmaceutical analytics line directly overlaps Pion's SiriusT3 and Rainbow R6 offerings, though it operates across many industries.
• Agilent Technologies: Large analytical instrument manufacturer serving pharmaceutical, biotech, and chemical markets. Comparable because Agilent's dissolution, spectroscopy, and lab automation portfolios directly overlap Pion's pharmaceutical analytical instrument offering, though it operates across many industries at much greater scale.
• Thermo Fisher Scientific: Global analytical instruments and lab products conglomerate. Comparable because its chromatography, spectroscopy, and laboratory instrument lines overlap with Pion's analytical workflows, even though Thermo Fisher operates at vastly greater scale and breadth.
• PerkinElmer: Diversified analytical sciences and life sciences instrumentation company. Comparable to Pion because its spectroscopy, chromatography, and lab automation offerings overlap with Pion's analytical instrument portfolio serving pharma customers, albeit at substantially larger scale.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BEE International